LinKinVax and Gustave Roussy Collaborate on a Phase I/IIa HP

CD40HVac, a therapeutic vaccine candidate in immuno-oncology targeting dendritic cells LinKinVax, a clinical-stage biotechnology company specialized in innovative protein-based vaccines, and Gustave

Related Keywords

Jacques Auberton Herv , Gustave Roussy , Corinne Margot , Centers For Disease , Instagram , Department Of Head , Linkedin , Twitter , Vaccine Research Institute , Facebook , European Cancer Centre , Best Cancer Hospital , Disease Control , Yves Levy , Chief Medical , Scientific Officer Linkinvax , Caroline Even , Neck Oncology , Honorary Chairman , Paris Saclay Cancer , Linkinvax , Gustave , Moussy , Ollaborate , Hase , Cvax , Linical , Trial , Treatment , Patients , Positive , Oropharyngeal , Dancer ,